Log ind
peter mørch eriksen.jpg
Foto: BioPorto PR

BioPorto chief: ”Strategically, it’s of exceptional importance”

Top picks in English:

BioPorto has released two positive announcements in the span of a week, and more are set to follow as the diagnostics company intends to increase its news flow in the run-up to a pivotal US approval.


BY ELIZABETH MØNSTED JOHANSEN
Offentliggjort 08.02.17 kl. 09:34

Log ind for at læse artikler

Velkommen til MedWatch. En del af vores indhold er eksklusivt og forbeholdt vores brugere.

Prøv os gratis i 14 dage

Få fuld adgang til vores kvalitetsjournalistik med et gratis prøveabonnement.

Sign up for MedWatch newsletter
Mest læste Top picks in English

Onxeo cleared to continue liver cancer study

Judith Greciet - Onxeo.jpg Top picks in English:

French-Danish biotech Onxeo has now received the recommendation to continue an important phase III study with its liver candidate drug Livatag. The first data from the study are expected soon.

Here is what Danish drug companies pay their workers

Top picks in English:

The average monthly salary in the private pharmaceutical industry in Denmark is DKK 57,109. Make the jump to find out which company pays the highest wages and learn how much the rest of the industry pays as well.

Danish hearing aid giants in global showdown

Top picks in English:

The world’s largest hearing device dealer, Amplifon, expresses concern over the entry into the retail market of manufacturers such as William Demant. GN Resound, on the other hand, receives praise and is expected to form even closer ties to its Italian collaborator.

Novo Seeds launches new biotech company

Top picks in English:

Novo Seeds has teamed up with innovation incubator Borean to inject millions in a “very exciting project”, which the investment company was made aware of by an executive at ALK through a third company. Moreover, they have attracted a foreign profile to the role as chairman.

Novo among the 100 most valuable companies in the world

Top picks in English:

Novo Nordisk has made it onto the list of the world’s 100 most valuable companies for the first time, but the Danish company is still trailing the biggest players in the pharmaceutical industry.

Leo director: New recommendation is an important first step

Top picks in English:

Leo Pharma has won a positive CHMP-recommendation of the biological drug brodalumab – an important milestone in the company’s gamble on biologics “This shows that we take the biological field seriously,” says its R&D chief.

Forsiden lige nu

Life science-aktier på himmelfart i ferieuge

COLOURBOX2143365[1].jpg Medicinal & Biotek:

Der var markante stigninger for en lang række life science-selskaber på fondsbørsen i en uge, der blev næsten halveret af Kristi himmelfartsferien.

GSK fordobler tilbagekaldelse af astmainhalatorer

Medicinal & Biotek:

GlaxoSmithKline trækker endnu engang flere partier af en udbredt type inhalator brugt i astma- og KOL-behandling tilbage fra det amerikanske marked. Tilbagekaldelsen er nu samlet set på mere end 1,1 millioner enheder.

Forbrugere stoler mere på robotkirurger end robotrådgivere

Medico & Rehab:

Forbrugerne vil hellere have foretaget en hjerteoperation af en robot end at betro en robot opgaven at åbne en opsparingskonto, viser en undersøgelse foretaget af den britiske storbank HSBC. Det skriver Finextra.

Insulinprodukt fra Novo Nordisk stagnerer i USA

Medicinal & Biotek:

Salget af Novo Nordisks insulinprodukt Tresiba har tabt pusten i USA, skriver Børsen.

Nordea tror på fortsat fremgang i William Demant-aktien

Medico & Rehab:

Mens investeringsbanken Berenberg sænker sin anbefaling til William Demant-aktien, hæver Nordea sin.

FDA: Nye Martin Shkrelis skal stoppes, før de begynder

Medicinal & Biotek:

Den nye direktør for de amerikanske lægemiddelmyndigheder sætter gang i en række nye tiltag, der skal stoppe folk, der vil gå i Martin Shkrelis fodspor.

ANNONCE
ANNONCE


ANNONCE